The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as ...

The FDA announced a new fast-track approval program for domestic drug developers for projects that are national priorities.

The UK Parole Board revealed it had made the decision not to release Glitter, whose real name is Paul Gadd, after a paper ...